Cogentix Medical (CGNT) Misses Q4 EPS by 6c

Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of $0.16, $0.06 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $125 million versus the consensus estimate of $129.55 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS